Ankerstar Wealth’s Harmony Biosciences HRMY Stock Holding History

Ankerstar Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401	Hold	11	–	–	﹤0.01%	717
2026 Q1	$308	Buy	11 +4	+57%	+$131	﹤0.01%	753
2025 Q4	$262	Buy	+7	New	+$230	﹤0.01%	822

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ankerstar Wealth's HRMY Position: Q2 2026 in Review

Ankerstar Wealth held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 11 shares worth $401. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Ankerstar Wealth first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Ankerstar Wealth held 11 shares of Harmony Biosciences worth $401 as of Q2 2026.
Ankerstar Wealth left its Harmony Biosciences share count unchanged in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Ankerstar Wealth's portfolio in Q2 2026, its #717 holding.
Ankerstar Wealth first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.